Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W Lo

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Plos One|July 25, 2022
Real-time extended psychophysiological analysis of financial risk processingManish Singh, Qingyang Xu, Sarah J Wang, et al.
Gene Therapy|November 7, 2023
The estimated annual financial impact of gene therapy in the United StatesChi Heem Wong, Dexin Li, Nina Wang, et al.
Drug Discovery Today|November 26, 2013
Financing drug discovery for orphan diseasesDavid E Fagnan, Austin A Gromatzky, Roger M Stein, et al.
Drug Discovery Today|March 30, 2021
Accelerating glioblastoma therapeutics via venture philanthropyKien Wei Siah, Qingyang Xu, Kirk Tanner, et al.
Orphanet Journal of Rare Diseases|September 12, 2023
Financing repurposed drugs for rare diseases: a case study of Unravel BiosciencesBechara Abouarab, Christian Bazarian, Zied Ben Chaouch, et al.
Nature Medicine|June 19, 2024
How to pay for individualized genetic medicinesJulia M Y Pian, Nana Owusu, Julia Vitarello, et al.
Nature Biotechnology|December 9, 2017
Just how good an investment is the biopharmaceutical sector?Richard T Thakor, Nicholas Anaya, Yuwei Zhang, et al.
Plos One|December 28, 2020
A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidatesDonald A Berry, Scott Berry, Peter Hale, et al.
Drug Discovery Today|June 16, 2026
Estimating the global inventory of deprioritized clinical-stage drug development programs: Toward a market for shelved assetsAnnette Bakker, Tanisha Carino, Joonhyuk Cho, et al.
Therapeutic Innovation & Regulatory Science|August 27, 2022
Leveraging Patient Preference Information in Medical Device Clinical Trial DesignLiliana Rincon-Gonzalez, Wendy K D Selig, Brett Hauber, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Plos One|July 25, 2022
Real-time extended psychophysiological analysis of financial risk processingManish Singh, Qingyang Xu, Sarah J Wang, et al.
Gene Therapy|November 7, 2023
The estimated annual financial impact of gene therapy in the United StatesChi Heem Wong, Dexin Li, Nina Wang, et al.
Drug Discovery Today|November 26, 2013
Financing drug discovery for orphan diseasesDavid E Fagnan, Austin A Gromatzky, Roger M Stein, et al.
Drug Discovery Today|March 30, 2021
Accelerating glioblastoma therapeutics via venture philanthropyKien Wei Siah, Qingyang Xu, Kirk Tanner, et al.
Orphanet Journal of Rare Diseases|September 12, 2023
Financing repurposed drugs for rare diseases: a case study of Unravel BiosciencesBechara Abouarab, Christian Bazarian, Zied Ben Chaouch, et al.
Nature Medicine|June 19, 2024
How to pay for individualized genetic medicinesJulia M Y Pian, Nana Owusu, Julia Vitarello, et al.
Nature Biotechnology|December 9, 2017
Just how good an investment is the biopharmaceutical sector?Richard T Thakor, Nicholas Anaya, Yuwei Zhang, et al.
Plos One|December 28, 2020
A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidatesDonald A Berry, Scott Berry, Peter Hale, et al.
Drug Discovery Today|June 16, 2026
Estimating the global inventory of deprioritized clinical-stage drug development programs: Toward a market for shelved assetsAnnette Bakker, Tanisha Carino, Joonhyuk Cho, et al.
Therapeutic Innovation & Regulatory Science|August 27, 2022
Leveraging Patient Preference Information in Medical Device Clinical Trial DesignLiliana Rincon-Gonzalez, Wendy K D Selig, Brett Hauber, et al.
Pageof 7